CLDX position history
The shares of Celldex Therapeutics (CLDX) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q3: 24,518 shares, $634K, 0.16% of portfolio, New
- 2025 Q4: 68,518 shares, $1.9M, 0.43% of portfolio, Add +179.5%
- 2026 Q1: 68,518 shares, $2.2M, 0.49% of portfolio
- 2026 Q2: 68,518 shares, $2.5M, 0.49% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|